Insider Shareholders with Direct Ownership of Hepion Pharmaceuticals, Inc. (HEPA)
This section provides a comprehensive overview of the insiders with direct ownership of Hepion Pharmaceuticals, Inc. (HEPA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Hepion Pharmaceuticals, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Robert T Foster
CEO and Director |
48,200 | 0 | 50,470 $25,235 | 4 |
Sep 18, 2023
Added 3.07%
|
John T Cavan
Chief Financial Officer |
14,500 | 0 | 14,800 $7,400 | 2 |
Feb 18, 2021
Added 40.32%
|
Gary S Jacob
Director |
12,000 | 0 | 12,059 $6,029 | 1 |
Dec 01, 2020
Added 49.88%
|
Peter Wijngaard
Director |
38,000 | 0 | 9,501 $4,750 | 6 |
Nov 27, 2023
Added 20.83%
|
John P Brancaccio
Chairman |
7,000 | 0 | 7,008 $3,504 | 1 |
Dec 02, 2020
Added 49.97%
|